CORECIVIC INC (CXW)       10.45  -0.16 (-1.51%)

10.45  -0.16 (-1.51%)

US21871N1019 - Common Stock - After market: 10.45 0 (0%)


Fundamental Rating

4

Overall CXW gets a fundamental rating of 4 out of 10. We evaluated CXW against 99 industry peers in the Commercial Services & Supplies industry. CXW has a bad profitability rating. Also its financial health evaluation is rather negative. A decent growth rate in combination with a cheap valuation! Better keep an eye on CXW.




Profitability

Profitability Rating

3

CXW has a Return On Assets of 3.85%. This is comparable to the industry average of 4.29%.
CXW has a Profit Margin of 6.82%. This is comparable to the industry average of 5.01%.

CXW has a Piotroski-F score of 6.00. This indicates an average health and profitability for CXW.
CXW's Return On Equity of 8.98% is worse than the rest of the industry. The industry average Return On Equity is 11.64%.
VS Industry

ROA (3.85%) VS Industry: 43% outperformed.

0.13
19.23

ROE (8.98%) VS Industry: 39% outperformed.

0.31
86.43

Profit Margin (6.82%) VS Industry: 56% outperformed.

0.26
34.12

Valuation

Valuation Rating

8

With a Price/Earnings Ratio of 9.86, the valuation of CXW can be described as very reasonable.
Compared to an average industry Price/Earning Ratio of 20.02, CXW is valued a bit cheaper than its industry peers.
With a Forward Price/Earnings Ratio of 8.66, the valuation of CXW can be described as very reasonable.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the current price to the book value of CXW, it is valued rather cheaply. It is trading at 0.86 times its book value.
When comparing the price book ratio of CXW to the average industry price book ratio of 2.19, CXW is valued rather cheaply. CXW is also cheaper than 83% of the companies listed in the same industry.
Compared to an average industry Enterprise Value to EBITDA ratio of 11.28, CXW is valued rather cheaply
VS Industry

Price/Earnings (9.86) VS Industry: 80% outperformed.

161.84
4.76

Price/Book (0.86) VS Industry: 83% outperformed.

44.24
0.13

Enterprise Value/ EBITDA (7.21) VS Industry: 70% outperformed.

262.88
2.58

Growth

Growth Rating

6

The Earnings Per Share has grown by an impressive 857.14% over the past year.
The Earnings Per Share is expected to grow by 81.99% on average over the next 5 years. This is a very strong growth
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.

Looking at the last year, CXW shows a decrease in Revenue. The Revenue has decreased by -0.96% in the last year.
CXW shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 0.14% yearly.
Based on estimates for the next 5 years, CXW will show a small growth in Revenue. The Revenue will grow by 3.29% on average per year.
Measured over the past 5 years, CXW shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -30.41% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-30.41% -39.36% 857.14% 207.89% 97.32% 81.99% N/A
Revenue0.14% 0.48% -0.96% -1.53% 1.47% 3.29% N/A

Health

Health Rating

2

CXW has a Current Ratio of 1.12. This is a normal value and indicates that CXW is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.12 indicates that CXW should not have too much problems paying its short term obligations.
The Quick Ratio is in line with the industry averages, which is at 1.14.
The Debt to Equity ratio of CXW is in line with the industry averages.

The Piotroski-F score of CXW is 6.00. This is a neutral score and indicates average health and profitability for CXW.
When comparing the Current Ratio of CXW to the average industry Current Ratio of 1.34, CXW is less able to pay its short term obligations than its industry peers.
CXW has an Altman-Z score of 0.99. This is a bad value and indicates that CXW is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of CXW to the average industry Altman-Z score of 1.86, CXW is less financially healthy than its industry peers.
VS Industry

Debt/Equity (0.79) VS Industry: 41% outperformed.

35.82
0.00

Quick Ratio (1.12) VS Industry: 45% outperformed.

0.02
40.95

Current Ratio (1.12) VS Industry: 32% outperformed.

0.02
40.95

Altman-Z (0.99) VS Industry: 27% outperformed.

-39.85
29.37

Dividend

Dividend Rating

0

No dividends for CXW!.

CORECIVIC INC10.45

NYSE:CXW (2/3/2023, 7:04:00 PM)-0.16 (-1.51%)

After market: 10.45 0 (0%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Commercial & Professional Services
GICS Industry Commercial Services & Supplies
Earnings (Last) 11-02 2022-11-02/amc Earnings (Next) 02-07 2023-02-07/amc
Inst Owners 73.78% Inst Owner Change -0.23%
Ins Owners 2.3% Ins Owner Change -6.15%
Market Cap 1.20B Analysts 83.33
Price Target 16.32 (56.17%)

Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y) N/A DP 0.7%
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -6.66%
Min EPS beat(2) -41.88% Max EPS beat(2) 28.56%
EPS beat(4) 1 Avg EPS beat(4) -8.44%
Min EPS beat(4) -41.88% Max EPS beat(4) 28.56%
Revenue beat(2) N/A Avg Revenue beat(2) -1.07%
Min Revenue beat(2) -1.71% Max Revenue beat(2) -0.42%
Revenue beat(4) N/A Avg Revenue beat(4) -2.26%
Min Revenue beat(4) -4.03% Max Revenue beat(4) -0.42%
PT rev (1m) 0% PT rev (3m) 0%
EPS NQ rev (1m) 0% EPS NQ rev (3m) 99.99%
EPS NY rev (1m) 0% EPS NY rev (3m) 20.13%
Revenue NQ rev (1m) 0% Revenue NQ rev (3m) 0.73%
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0.31%

Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 8.66
P/S 0.65
P/FCF 65.1
P/OCF 12.35
P/B 0.86
P/tB 0.86
EV/EBITDA 7.21
EPS(TTM) 1.06 EY 10.14%
EPS(NY) 1.21 Fwd EY 11.55%
FCF(TTM) 0.16 FCFY 1.54%
OCF(TTM) 0.85 OCFY 8.1%
SpS 16.06 BVpS 12.19
TBVpS 12.15 PEG (NY) 0.05
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 3.85%
ROE 8.98%
ROIC 5.36%
ROICexc 5.74%
ROICexgc 5.75%
OM 10.29%
PM 6.82%
GM 24.45%
ROICexgc(3y) 6.47% ROICexcg growth 3Y 3.04%
ROICexcg growth 5Y -2.96% ROICexc(3y) 6.41%
ROICexc growth 3Y 3.94% ROICexc growth 5Y -2.53%
OM growth 3Y -0.76% OM growth 5Y -3.35%
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y -0.16% GM growth 5Y -1.89%
F-Score 6 Asset Turnover 0.56

Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 69.97
Debt/EBITDA 4.04
Cap/Depr 60.55%
Profit Quality 14.66%
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 0.99
F-Score 6 WACC 8.2%
ROIC/WACC 0.7 Cap/Depr(3y) 83.08%
Cap/Depr(5y) 75.42% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 857.14% EPS 3Y -39.36%
EPS 5Y -30.41% EPS growth Q2Q 132%
EPS Next Y 207.89% EPS Next 2Y 97.32%
EPS Next 3Y 81.99% EPS Next 5Y N/A
Revenue growth 1Y -0.96% Revenue growth 3Y 0.48%
Revenue growth 5Y 0.14% Revenue growth Q2Q -1.48%
Revenue Next Year -1.53% Revenue Next 2Y 1.47%
Revenue Next 3Y 3.29% Revenue Next 5Y N/A
EBIT growth 1Y -25.53% EBIT growth 3Y -0.28%
EBIT growth 5Y -3.22% EBIT Next Year 62.47%
EBIT Next 3Y 21.88% EBIT Next 5Y N/A
FCF growth 1Y -92.18% FCF growth 3Y -3.23%
FCF growth 5Y -8.34% OCF growth 1Y -70.68%
OCF growth 3Y -6.58% OCF growth 5Y -6.85%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA